Skip to main content
Clinical Trials/NCT00296738
NCT00296738
Completed
Not Applicable

Quantitative 123I-MIBG SPECT/CT Assessment of Cardiac Sympathetic Innervation

Rambam Health Care Campus1 site in 1 country50 target enrollmentMay 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Diseases
Sponsor
Rambam Health Care Campus
Enrollment
50
Locations
1
Primary Endpoint
The impact of the imaging modality on patient management
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
May 2010
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The impact of the imaging modality on patient management

Time Frame: 2 years

Secondary Outcomes

  • The impact on patient management(2 years)

Study Sites (1)

Loading locations...

Similar Trials